查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434571

醫用生物聚合物市場：按類型、來源、應用分類 - 2023-2030 年全球預測

Biopolymers for Medical Applications Market by Type (Bio-Based Polyethylene, Bio-degradable Starch Blends, Bio-PC), Source (Natural, Synthetic), Application - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2022年醫用生物聚合物市場規模為19.8億美元，預計2023年將達24.3億美元，2030年將達到105.2億美元，複合年成長率為23.22%。

醫用生物聚合物的全球市場

主要市場統計
基準年[2022] 19.8億美元
預測年份 [2023] 24.3億美元
預測年份 [2030] 105.2億美元
複合年成長率（%） 23.22%
醫用生物聚合物市場-IMG1

由於現代醫療產業不斷變化的需求，醫用生物聚合物市場正在經歷顯著成長。這些天然和生物合成的聚合物對於製造尖端醫療工具和設備至關重要，例如可生物分解性的支架、藥物傳輸系統和縫合線，所有這些都與人體相容，因其耐用性、自然分解性而受到高度評價，且毒性低。其應用範圍廣泛，包括再生醫學、製藥和外科手術。對生物相容性材料的需求迅速成長、生物聚合物的突破性技術進步以及慢性病患病率的上升推動了市場的擴張。該市場充滿了充滿希望的機會，包括具有提高的生產效率和智慧功能特性（例如刺激響應性）的新型生物聚合物。然而，該行業面臨一定的限制，包括不斷上升的研發成本、嚴格的監管環境以及來自合成聚合物的激烈競爭。毫無疑問，創新和研究至關重要，包括開發滿足特定醫療需求的生物聚合物並最佳化其臨床使用性能。此外，探索永續生產方法並與醫療保健公司建立牢固的關係是發展這個令人興奮的領域的關鍵。

區域洞察

美國由於其強大的醫療基礎設施而處於醫用生物聚合物消費和創新的前沿。先進的醫療設施、不斷成長的老年人口以及對永續材料的強烈關注正在推動需求。加拿大的努力與美國一致，強調生態影響以及將生物聚合物整合到先進的傷口護理和整形外科中。北美擁有最新的專利、研究和投資，是生物聚合物創新的發源地。歐盟國家正積極努力減少對環境的影響，並積極支持生物聚合物在醫療領域的應用。大部分需求受到該地區醫療設備和材料強力的法律規範的影響，特別是環保和永續的醫療設備和材料。歐盟最近的投資大量湧入專門研究生物聚合物的研究機構，歐洲專利局等機構繼續發布新專利，展示了充滿活力的創新格局。中國、日本和印度是亞太地區生物聚合物市場的領先參與者。該地區代表了一個消費者需求多樣化的市場，從印度負擔得起的醫療保健解決方案到日本先進的醫療技術。

FPNV定位矩陣

FPNV定位矩陣對於評估醫用生物聚合物市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對醫用生物聚合物市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-醫用生物聚合物市場的市場規模與預測是多少？

2-在醫用生物聚合物市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-醫用生物聚合物市場的技術趨勢和法律規範是什麼？

4-醫用生物聚合物市場主要供應商的市場佔有率是多少？

5-進入醫用生物聚合物市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療設備和植入製造對生物聚合物的需求增加
      • 擴大生物聚合物在先進影像和骨骼組織特異性治療的應用
      • 生物高分子滅菌技術的開發
    • 抑制因素
      • 與生物聚合物相關的性能問題
    • 機會
      • 生物聚合物創新與永續生產
      • 奈米顆粒藥物傳輸系統在癌症中的普及
    • 任務
      • 與合成生物聚合物相關的生物相容性問題
  • 市場區隔分析
    • 類型：日益增強的永續性導向強調生物聚合物的醫療應用
    • 資料來源：合成生物聚合物由於其增強的生物相容性、生物功能性、機械性能、分解率和免疫抗原性而受到越來越多的需求
    • 應用：透過提升組織生成能力，擴大在藥物發現和傷口閉合方面的應用
  • 市場趨勢分析
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化
    • 專利分析及趨勢

第6章醫用生物聚合物市場：依類型

  • 生物基聚乙烯
  • 生物分解性澱粉混合物
  • 生物電腦
  • Bio-Pet
  • 生物聚氨酯
  • 纖維素衍生物
  • Pha
  • 再生纖維素

第7章醫用生物聚合物市場：依來源分類

  • 自然的
  • 合成

第8章醫用生物聚合物市場：依應用分類

  • 生物可吸收支架
  • 牙科
  • 藥物輸送系統
  • 治療產品
  • 手術植入裝置
  • 治療影像處理
  • 傷口縫合

第9章美洲醫用生物聚合物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫用生物聚合物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲醫用生物聚合物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 併購
    • 獎項/獎勵/擴展

第13章競爭產品組合

  • 主要公司簡介
    • BASF SE
    • Biesterfeld AG
    • BioPolymer GmbH & Co. KG
    • Blafar Ltd.
    • Corbion NV
    • Danimer Scientific, Inc.
    • DuPont de Nemours, Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Geistlich Pharma AG
    • GELITA AG
    • Green Dot Bioplastics Inc.
    • HTL
    • HyMedPoly
    • Invibio Ltd. by Victrex PLC
    • ITV Denkendorf Product Service GmbH
    • Merck & Co., Inc.
    • NatureWorks LLC
    • Rodenburg Productie BV
    • Solvay SA
    • SolyPlus GmbH
    • Symatese
    • Tate & Lyle PLC
    • Thermo Fisher Scientific, Inc.
    • Toray Industries Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-435FD7709B84

[184 Pages Report] The Biopolymers for Medical Applications Market size was estimated at USD 1.98 billion in 2022 and expected to reach USD 2.43 billion in 2023, at a CAGR 23.22% to reach USD 10.52 billion by 2030.

Global Biopolymers for Medical Applications Market

KEY MARKET STATISTICS
Base Year [2022] USD 1.98 billion
Estimated Year [2023] USD 2.43 billion
Forecast Year [2030] USD 10.52 billion
CAGR (%) 23.22%
Biopolymers for Medical Applications Market - IMG1

Biopolymer market for medical applications is experiencing significant growth owing to the ever-evolving demands of the modern healthcare industry. These natural or biologically synthesized polymers are essential in the creation of cutting-edge medical tools and devices, including biodegradable stents, drug delivery systems, and sutures, all admired for their compatibility with the human body, natural decomposition, and reduced toxicity. Their applications are diverse, spanning regenerative medicine, pharmaceuticals, and surgical procedures. Market expansion is fueled by the surging need for biocompatible materials, groundbreaking technological progression in biopolymers, and a rising prevalence of chronic diseases. The market teems with opportunities, promising advances in production efficiency and novel biopolymers featuring smart functional properties such as stimuli-responsiveness. Nevertheless, the industry faces certain constraints, including the steep costs of research and development, stringent regulatory landscapes, and stiff competition from synthetic polymers. Undoubtedly, innovation and research are pivotal, focusing on developing tailored biopolymers for specific medical needs and optimizing performance to align with clinical applications. Additionally, exploring sustainable production methods and forging strong relationships with healthcare entities will be instrumental in advancing this exciting field.

Regional Insights

The United States is at the forefront in the consumption and innovation of biopolymers for medical applications due to its robust medical infrastructure. The demand is driven by advanced healthcare facilities, a growing elderly population, and a strong focus on sustainable materials. Canadian efforts align with those of the US, emphasizing ecological impact and the integration of biopolymers in advanced wound care and orthopedics. In terms of latest patents, research and investment, North America is a productive ground for innovation in biopolymer technology. EU countries exhibit a robust commitment to reducing environmental impact, which translates to active support for biopolymer applications in the medical sector. Much of the demand is influenced by the region's strong regulatory framework for medical devices and materials, particularly those that are eco-friendly and sustainable. Recent investments in the EU are funneled into research institutions focusing on biopolymers, and institutions such as the European Patent Office showcase a steady stream of new patents, indicating a dynamic innovation landscape. In Asia Pacific's biopolymer market, China, Japan, and India are prominent players. The region presents a diverse market with consumer needs varying from affordable healthcare solutions in India to advanced medical technologies in Japan.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopolymers for Medical Applications Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopolymers for Medical Applications Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopolymers for Medical Applications Market, highlighting leading vendors and their innovative profiles. These include BASF SE, Biesterfeld AG, BioPolymer GmbH & Co. KG, Blafar Ltd., Corbion NV, Danimer Scientific, Inc., DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries AG, Geistlich Pharma AG, GELITA AG, Green Dot Bioplastics Inc., HTL, HyMedPoly, Invibio Ltd. by Victrex PLC, ITV Denkendorf Product Service GmbH, Merck & Co., Inc., NatureWorks LLC, Rodenburg Productie B.V., Solvay S.A., SolyPlus GmbH, Symatese, Tate & Lyle PLC, Thermo Fisher Scientific, Inc., and Toray Industries Inc..

Market Segmentation & Coverage

This research report categorizes the Biopolymers for Medical Applications Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Bio-Based Polyethylene
    • Bio-degradable Starch Blends
    • Bio-PC
    • Bio-PET
    • Bio-PUR
    • Cellulose Derivatives
    • PHA
    • Regenerated Cellulose
  • Source
    • Natural
    • Synthetic
  • Application
    • Bioresorbable Scaffolds
    • Dentistry
    • Drug Delivery Systems.
    • Healing Products
    • Surgical Implant Devices
    • Therapeutic Imaging
    • Wound Closure
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopolymers for Medical Applications Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopolymers for Medical Applications Market?

3. What are the technology trends and regulatory frameworks in the Biopolymers for Medical Applications Market?

4. What is the market share of the leading vendors in the Biopolymers for Medical Applications Market?

5. Which modes and strategic moves are suitable for entering the Biopolymers for Medical Applications Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biopolymers for Medical Applications Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Biopolymers demand for Manufacturing of Medical Devices and Implants
      • 5.1.1.2. Growing Adoption of Biopolymers for Advanced Imaging and Skeletal Tissue-Specific Therapeutics
      • 5.1.1.3. Development of Sterilization Technology for Biopolymers
    • 5.1.2. Restraints
      • 5.1.2.1. Performance Issues Associated with the Biopolymers
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations and Sustainable Production of Biopolymers
      • 5.1.3.2. Proliferation of Nano-Particle Drug Delivery Systems in Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Biocompatibility Issues Associated with Synthetic Biopolymers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising inclination toward the sustainability is emphasizing focus on application of biopolymers healthcare
    • 5.2.2. Source: Synthetic biopolymers are in demand due to enhanced biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity
    • 5.2.3. Application: Expandable use in drug discovery, and wound closure owing to the rising tissue generation capability
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework
  • 5.10. Client Customization
    • 5.10.1. Patent Analysis & Trend

6. Biopolymers for Medical Applications Market, by Type

  • 6.1. Introduction
  • 6.2. Bio-Based Polyethylene
  • 6.3. Bio-degradable Starch Blends
  • 6.4. Bio-PC
  • 6.5. Bio-PET
  • 6.6. Bio-PUR
  • 6.7. Cellulose Derivatives
  • 6.8. PHA
  • 6.9. Regenerated Cellulose

7. Biopolymers for Medical Applications Market, by Source

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Biopolymers for Medical Applications Market, by Application

  • 8.1. Introduction
  • 8.2. Bioresorbable Scaffolds
  • 8.3. Dentistry
  • 8.4. Drug Delivery Systems.
  • 8.5. Healing Products
  • 8.6. Surgical Implant Devices
  • 8.7. Therapeutic Imaging
  • 8.8. Wound Closure

9. Americas Biopolymers for Medical Applications Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopolymers for Medical Applications Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopolymers for Medical Applications Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. DuPont Completes Acquisition of Spectrum Plastics Group
      • 12.3.1.2. Sanofi completes acquisition of Provention Bio, Inc.
    • 12.3.2. Award, Recognition, & Expansion
      • 12.3.2.1. Victrex Invests In New Medical Device Product Development Centre And Manufacturing Expansion

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. BASF SE
    • 13.1.2. Biesterfeld AG
    • 13.1.3. BioPolymer GmbH & Co. KG
    • 13.1.4. Blafar Ltd.
    • 13.1.5. Corbion NV
    • 13.1.6. Danimer Scientific, Inc.
    • 13.1.7. DuPont de Nemours, Inc.
    • 13.1.8. Eastman Chemical Company
    • 13.1.9. Evonik Industries AG
    • 13.1.10. Geistlich Pharma AG
    • 13.1.11. GELITA AG
    • 13.1.12. Green Dot Bioplastics Inc.
    • 13.1.13. HTL
    • 13.1.14. HyMedPoly
    • 13.1.15. Invibio Ltd. by Victrex PLC
    • 13.1.16. ITV Denkendorf Product Service GmbH
    • 13.1.17. Merck & Co., Inc.
    • 13.1.18. NatureWorks LLC
    • 13.1.19. Rodenburg Productie B.V.
    • 13.1.20. Solvay S.A.
    • 13.1.21. SolyPlus GmbH
    • 13.1.22. Symatese
    • 13.1.23. Tate & Lyle PLC
    • 13.1.24. Thermo Fisher Scientific, Inc.
    • 13.1.25. Toray Industries Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET DYNAMICS
  • FIGURE 7. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 10. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-BASED POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-DEGRADABLE STARCH BLENDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIO-PUR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 15. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BIORESORBABLE SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY SYSTEMS., BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HEALING PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL IMPLANT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY THERAPEUTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 153. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 154. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET LICENSE & PRICING